Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166694 · ClinicalTrials.gov registry record · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
A NA study of Cancer and Advanced Solid Tumor, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 1,300
- Enrollment target
- 1
- Study location
NCT05166694 is a NA study of Cancer and Advanced Solid Tumor that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,300 participants, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05166694, a NA study of Cancer and Advanced Solid Tumor, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Drug-Drug Interaction Profile
- OTHER Drug-Gene Interaction Profile
Study Locations (1)
Illinois
- University of Chicago Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2027-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05166694
The ClinicalTrials.gov registry entry for NCT05166694 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (63% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT05166694 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05166694 about?
NCT05166694 is a clinical study titled "Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions". The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions f...
What is the current status of trial NCT05166694?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,300 participants. The study started on 2022-11-30. Estimated completion is 2027-11-01.
What conditions does trial NCT05166694 study?
This clinical trial studies the following conditions: Cancer, Advanced Solid Tumor, Advanced Cancer, Mental Health Issue, Behavior Disorders.
What interventions are being tested in trial NCT05166694?
The interventions under investigation include: Standard of Care (OTHER), Drug-Drug Interaction Profile (OTHER), Drug-Gene Interaction Profile (OTHER).
Who is sponsoring clinical trial NCT05166694?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05166694 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.